Brief report · 30 Jun 2026
Research articlePublished 2019
Novel Chiral Chalcone Analogs that Induce M Phase Arrest and Apoptosis in HeLa Cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We identified two chiral chalcone analogs CCL360 and CCL361 from the Chiba Chemical Library, which exhibit antiproliferative effects on human cancer cells. Flow cytometry analyses revealed that HeLa and Vero cells treated with CCL360 and CCL361 had higher populations of cells in the G2/M phase than untreated cells. Docking studies suggested that the R-isomer of CCL361 binds to the taxol binding domain (TBD) of β-tubulin, and the S-isomers of CCL360 and CCL361 bind to β-tubulin at the colchicine binding domain and the TBD. Further investigations using a fluorescent ubiquitination-based cell cycle indicator system revealed that the two compounds caused cell cycle arrest (in the M phase) and apoptosis only in HeLa cells. In non-cancerous Vero cells, however, CCL360 and CCL361 prolonged the G2/M phase without causing apoptosis. Although increased expression levels of p53 and p21 were observed in all CCL360/361-treated cells, only HeLa cells exhibited increased levels of cleaved poly (ADP-ribose) polymerases and apoptosis. Increases in G2/M phase populations in CCL360/361-treated cells are likely caused by increases in p-histone H3 (at Ser10) and Cyclin B1 levels. Furthermore, CCL360/361-treated HeLa cells exhibited phosphorylation of p-Plk1 (at Thr210) and dephosphorylation of p-Cdc2 (at Tyr15); these changes were not evident in CCL360/361-treated Vero cells, suggesting that the link between p53 and Plk1 in HeLa cells was likely compromised. Our study indicates that CCL360 and CCL361 are microtubule-targeting agents that can be used as lead compounds for developing novel anticancer drugs.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Weiwei Chen”
- BylineArticles whose byline prints “Ruirong Yi”
- BylineArticles whose byline prints “Majid Vahed”
- BylineArticles whose byline prints “Yoshifumi Ohno”
- BylineArticles whose byline prints “Zheng Tian”
- BylineArticles whose byline prints “Shuhan Guo”
- BylineArticles whose byline prints “Xue Ma”
- BylineArticles whose byline prints “Nan Nwe Win”
